Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Belinostat |
Trade Name | Beleodaq |
Synonyms | PDX101|NSC726630|PX-105684 |
Drug Descriptions |
Beleodaq (belinostat) is an HDAC inhibitor, which promotes tumor cell apoptosis, potentially leading to decreased tumor growth (PMID: 12939461, PMID: 16928830, PMID: 17935615). Beleodaq (belinostat) is FDA approved for patients with relapsed or refractory peripheral T-cell lymphoma (FDA.gov). |
DrugClasses | HDAC Inhibitor 45 |
CAS Registry Number | 414864-00-9 |
NCIT ID | C48812 |